Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$10.27 - $13.29 $29,783 - $38,541
-2,900 Reduced 22.48%
10,000 $106,000
Q3 2022

Oct 18, 2022

SELL
$9.93 - $17.44 $60,573 - $106,384
-6,100 Reduced 32.11%
12,900 $18,000
Q2 2022

Aug 03, 2022

BUY
$7.45 - $12.83 $141,550 - $243,770
19,000 New
19,000 $32,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Firethorn Wealth Partners, LLC Portfolio

Follow Firethorn Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Firethorn Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Firethorn Wealth Partners, LLC with notifications on news.